INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
BK

Bitterman Kevin

DirectorCIK 0001591747

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 9
Max Insider Score11
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$475K
5,937 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Disc Medicine, Inc.Director · Oct 21, 2026
11
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL
$395K
4,942 sh
Oct 19, 2026
Oct 21, 2026
traded Oct 19, 2026
+2d
SEC FORM 4

Evidence

5
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$9,197
115 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
2,869 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$191K
2,388 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

1
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$4,397
55 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

7
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
13.8K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC FORM 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$920K
11.5K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC FORM 4

Evidence

0
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
266 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC FORM 4

Evidence